Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Weight Loss 1Pancreatic Neoplasms 1Disease 1Cachexia 1Adenocarcinoma 1

Interventions

Colonoscopy 5Surveys and Questionnaires 3Methods 2Liquid Biopsy 2Interviews as Topic 2Exercise 2Capecitabine 2Biopsy, Fine-Needle 2Bevacizumab 2weifuchun 1tislelizumab 1pembrolizumab 1irinotecan sucrosofate 1fluorocholine 1bermekimab 1Water 1Therapeutics 1TKM-080301 1Surgical Procedures, Operative 1Standard of Care 1S-Adenosylmethionine 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Nutritional Status 1Nutrition Assessment 1Needles 1MicroRNAs 1Magnetic Resonance Imaging 1Interleukin-15 1High-Intensity Interval Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × bermekimab × Gastrointestinal × Clear all
NCT03207724 2020-12-30

OnFX

Cedars-Sinai Medical Center

Phase 1 Completed
16 enrolled
Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡